Reducing Drug-Related Harms and Promoting Health Justice Worldwide During and After COVID-19: An

Ryan McNeil, Marie Jauffret-Roustide, Helena Hansen

Abstract readEditorial

In one paragraph

Article in American journal of public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it

0cells of the map it votes in

4citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

Mechanisms of overdose from unintentional fentanyl use when intending to use stimulants: a qualitative study of people who use stimulants and avoid opioids.Research square · 2026
Article
Key and evolving needs of service providers in women's harm reduction centers during the COVID-19 pandemic.Harm reduction journal · 2025
Article
The Clinical Evolutions of Surveillance and Violence During Three Contemporary US Crises: Opioid Overdose, COVID-19, and Racial Reckoning.Culture, medicine and psychiatry · 2024
Article
Patient perspectives on naloxone receipt in the emergency department: a qualitative exploration.Harm reduction journal · 2022
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ryan McNeilRyan McNeil is with the Program in Addiction Medicine, Yale University, New Haven, CT. Marie Jauffret-Roustide is with Centre d'Études des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France, and the Social Science, Drugs and Society Program, Paris, France. Helena Hansen is with the Research Theme in Health Equity Research and Translational Social Science, David Geffen School of Medicine, University of California, Los Angeles. The authors are also Guest Editors for this supplement issue.

Marie Jauffret-RoustideRyan McNeil is with the Program in Addiction Medicine, Yale University, New Haven, CT. Marie Jauffret-Roustide is with Centre d'Études des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France, and the Social Science, Drugs and Society Program, Paris, France. Helena Hansen is with the Research Theme in Health Equity Research and Translational Social Science, David Geffen School of Medicine, University of California, Los Angeles. The authors are also Guest Editors for this supplement issue.

Helena HansenRyan McNeil is with the Program in Addiction Medicine, Yale University, New Haven, CT. Marie Jauffret-Roustide is with Centre d'Études des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France, and the Social Science, Drugs and Society Program, Paris, France. Helena Hansen is with the Research Theme in Health Equity Research and Translational Social Science, David Geffen School of Medicine, University of California, Los Angeles. The authors are also Guest Editors for this supplement issue.

Funding

An ethno-epidemiological study of the implementation and effectiveness of an innovative and comprehensive response to the opioid epidemicR01DA044181 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI Thomas Kerr, Ryan McNeil · 2017 to 2026

$4.0M

NIDA NIH HHS R01 DA044181

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Dietary SupplementsHumans

Identifiers

PMID35349319

DOI10.2105/AJPH.2022.306804

PMCPMC8965184

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.